Your Article Summary
(Click the title below to leave the MDLinx Network and go to the Journal's Website)
Monitoring Bone Density Unnecessary, Potentially Misleading
Ivanhoe, 06/26/09
Regular bone mineral density monitoring in postmenopausal women may be unnecessary and potentially misleading. Researchers looked at how the effects of the drug alendronate (a widely used osteoporosis drug) differ between individuals. They found after three years therapy, almost all (97.5%) women treated with alendronate showed at least a modest increase in hip bone mineral density.
Today in Popular Press...keeping you current
Receive free subspecialty "5-minute updates" via email
Loneliness Can be Contagious
Ivanhoe, 12/04/09
New computer model could lead to safer stents
ScienceDaily, 12/03/09
Half of worlds ICU patients have infections
Reuters, 12/03/09

See Latest Articles